Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

Fig. 1

Liraglutide (Lira) maintains glucose homeostasis of T2DM mice. The effect of liraglutide on A body weight (BW) (n = 8), B fast blood glucose (FBG) (n = 8), C insulin (n = 5), D HOMA-IR (n = 5), E IPGTT (n = 8), F AUC of IPGTT(n = 8), G ITT (n = 8) and (H) AUC of ITT (n = 8) of T2DM mice. Data are expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns means no significant difference

Back to article page